Imricor Medical Systems, Inc. (IMR.AX)
AUD 1.25
(5.04%)
AUD 1.25
(5.04%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 14.48 Million AUD | 1309.11% |
| 2022 | -1.19 Million USD | 92.86% |
| 2021 | -16.77 Million AUD | 29.36% |
| 2020 | -23.75 Million AUD | -385.42% |
| 2019 | -4.89 Million AUD | 54.41% |
| 2018 | -10.73 Million AUD | -1578.82% |
| 2017 | 725.77 Thousand AUD | 220.25% |
| 2016 | -603.55 Thousand AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 6.65 Million USD | 18.88% |
| 2024 Q1 | 6.65 Million USD | -30.56% |
| 2023 Q1 | 4.14 Million USD | 446.46% |
| 2023 FY | 14.48 Million AUD | 1309.11% |
| 2023 Q3 | 9.15 Million USD | 120.64% |
| 2023 Q2 | 4.14 Million USD | 0.0% |
| 2023 Q4 | 9.58 Million USD | 4.73% |
| 2022 Q4 | -1.19 Million USD | 43.21% |
| 2022 FY | -1.19 Million USD | 92.86% |
| 2022 Q3 | -2.1 Million USD | 71.97% |
| 2022 Q1 | -7.52 Million USD | 55.15% |
| 2022 Q2 | -7.52 Million USD | 0.0% |
| 2021 Q3 | -17.29 Million USD | -19.09% |
| 2021 FY | -16.77 Million AUD | 29.36% |
| 2021 Q1 | -14.52 Million USD | 52.9% |
| 2021 Q4 | -16.77 Million AUD | 3.0% |
| 2021 Q2 | -14.52 Million USD | 0.0% |
| 2020 Q4 | -30.84 Million AUD | -32.35% |
| 2020 FY | -23.75 Million AUD | -385.42% |
| 2020 Q1 | -9.24 Million USD | -158.33% |
| 2020 Q2 | -9.24 Million USD | 0.0% |
| 2020 Q3 | -23.3 Million USD | -152.12% |
| 2019 Q4 | -3.57 Million USD | 0.0% |
| 2019 FY | -4.89 Million AUD | 54.41% |
| 2019 Q3 | -3.57 Million USD | -131.48% |
| 2019 Q2 | 11.36 Million USD | 0.0% |
| 2019 Q1 | 11.36 Million USD | 41.92% |
| 2018 FY | -10.73 Million AUD | -1578.82% |
| 2018 Q1 | 1.76 Million USD | 0.0% |
| 2018 Q3 | 8 Million USD | 0.0% |
| 2018 Q4 | 8 Million USD | 0.0% |
| 2017 FY | 725.77 Thousand AUD | 220.25% |
| 2016 FY | -603.55 Thousand AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| 4DMedical Limited | -25.48 Million AUD | 156.828% |
| Adherium Limited | -6.1 Million AUD | 337.256% |
| Aroa Biosurgery Limited | -3.74 Million AUD | 486.504% |
| Atomo Diagnostics Limited | -3.6 Million AUD | 501.931% |
| Anteris Technologies Ltd | -28.49 Million AUD | 150.819% |
| Control Bionics Limited | -19.02 Thousand AUD | 76237.499% |
| CardieX Limited | 2.74 Million AUD | -427.355% |
| Compumedics Limited | 5.08 Million AUD | -184.704% |
| Cochlear Limited | -269.9 Million AUD | 105.366% |
| CleanSpace Holdings Limited | 698.59 Thousand AUD | -1973.152% |
| Cyclopharm Limited | -7.49 Million AUD | 293.127% |
| EMVision Medical Devices Ltd | -15.7 Million AUD | 192.24% |
| Nova Eye Medical Limited | -2.8 Million AUD | 616.876% |
| HeraMED Limited | -799.34 Thousand AUD | 1911.836% |
| ImpediMed Limited | -23.48 Million AUD | 161.658% |
| InhaleRx Limited | -155.54 Thousand AUD | 9411.111% |
| LBT Innovations Limited | -604 Thousand AUD | 2497.827% |
| Micro-X Limited | 826.99 Thousand AUD | -1651.257% |
| Neurotech International Limited | -2.11 Million AUD | 786.236% |
| OncoSil Medical Limited | -4.43 Million AUD | 426.874% |
| PolyNovo Limited | -30.52 Million AUD | 147.443% |
| Respiri Limited | 413.68 Thousand AUD | -3400.909% |
| SomnoMed Limited | -15.16 Million AUD | 195.516% |
| Universal Biosensors, Inc. | -5.3 Million AUD | 373.059% |
| Uscom Limited | -1.53 Million AUD | 1046.202% |
| Visioneering Technologies, Inc. | -4.08 Million AUD | 454.716% |